InvestorsHub Logo

dreamer0

09/30/20 3:04 AM

#325746 RE: oldtimer investor #325745

Prior to that 10 Billions..we need peer Review report from RBL n FDA MTG clearance and of course other relevant events to support CT activities.

I hope we get 2c a PR in the coming days/weeks n not months? Regardless when the PR will b out..it will be phrased vaguely.

1. RBL(s) - pre peer review: Final stage.

2. FDA MTG - very productive/encouraging n ongoing

3. Manufacturing: All good to go!

4. New Hire: is it worthy to mention? We'll know when we it!

5. All in all...we're on track n moving along ...late Q4 2020- Q12021?

1a. According to our last PR, the paper should have been out by now (Sept?)...OK the DELAY is due to what?.. outstanding results?. Few folks had stated that the B results are going 2b outstanding n probably they're working on other viruses (PAN) etc..
1b. IF SO, are we going to see all that new developments/testing etc. Etc. in the coming PR or in the Pre-Peer Review report?
1c. Or IPIX CANNOT due to an NDA? Or
1d. There is nothing in those lines (additional testing) and we're ASSUMING all that extra-ordinary results etc? What's limiting them to share this MIND BOGGLING news with the world? Of course NDA.

We know..what we know from those PRs....I'm good with that! IMO...a delay could be as simple as gathering information n putting it together or other administrative related n has nothing to do with great results etc....we have NO CLUE bout that...it's purely based on speculation.

loanranger

09/30/20 7:54 AM

#325755 RE: oldtimer investor #325745

"Brilacidin bidding will start at 10 billion if reviews go well."
Fine. That's your opinion and that would be about 140 times the current market value.

So was this:
8/11....."The optimism for brilacidin will slowly fade like it has in the past. Its just a matter of time before we go beloe .10."

And your most recent opinion on 9/4 was...."by the time any results are released the pandemic will be just about over. The company has not delivered a product to market to date. A lot of potential and that is about it."